Schedule 13D ownership disclosure
Whitehawk Therapeutics, Inc.
Common stock, par value $0.0001 per share · CUSIP: 00032Q104
Event date: 2025-03-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BML Investment Partners, L.P.Reported CIK 0001373604
Shares: 1,971,137 · Class: 4.25%
- Leonard Braden MichaelReported CIK 0001373603
Shares: 2,435,000 · Class: 4.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000045
- Form type
- SCHEDULE 13D/A
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Mar 05, 2025
- Reporting period
- Mar 05, 2025
- Description
- Schedule 13D beneficial ownership